Saba Capital Management, L.P. bought HQL
May 15, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 34,755 shares of Abrdn Life Sciences Investors at $14.19 per share, a transaction worth $493.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
34,755
Price
$14.19
Total value
$493.2K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 15, 2024
Filing dateMay 17, 2024
Shares owned after3,250,580
OwnershipIndirect
10b5-1 planNo
AmendedNo